Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 2805291 | HLA (HLA) | cardiac transplantation | NA | NA | NA | unclassified | |
| relation between survival and development of coronary artery disease and anti-hla antibodies after cardiac transplantation. | |||||||
| 2805291 | HLA (HLA) | coronary artery disease | NA | NA | NA | unclassified | |
| relation between survival and development of coronary artery disease and anti-hla antibodies after cardiac transplantation. | |||||||
| 2805291 | HLA (HLA) | cardiac transplantation | NA | NA | NA | positive | |
| thus, the presence of anti-hla antibodies was associated with increased mortality and the development of coronary artery disease and was a major correlate of the clinical course after cardiac transplantation. | |||||||
| 2805291 | HLA (HLA) | coronary artery disease | NA | NA | NA | positive | |
| thus, the presence of anti-hla antibodies was associated with increased mortality and the development of coronary artery disease and was a major correlate of the clinical course after cardiac transplantation. | |||||||
| 2820089 | HLA MATCHED (HLA-MATCHED) | transplantation | NA | NA | NA | only_studied | |
| in this report, we describe a patient with severe aplastic anemia who developed a malignant b cell lymphoplasmacytoid proliferation 48 days after undergoing allogeneic marrow transplantation from her hla-matched mlc-nonreactive brother. | |||||||
| 2820089 | HLA MATCHED (HLA-MATCHED) | aplastic anemia | NA | NA | NA | only_studied | |
| in this report, we describe a patient with severe aplastic anemia who developed a malignant b cell lymphoplasmacytoid proliferation 48 days after undergoing allogeneic marrow transplantation from her hla-matched mlc-nonreactive brother. | |||||||
| 2827354 | HLA-DR (HLA-DR) | transplantation | NA | NA | NA | unclassified | |
| just prior to transplantation the percentages of leu2a+ cells, as well as the percentages of leu15+ and dr+ cells within this population, varied considerably. | |||||||
| 2827354 | HLA-DR (HLA-DR) | infections | NA | NA | NA | lack_of_evidence | |
| a decreased percentage of leu2a+ cells, together with increased percentages of leu15+ and dr+ cells, was seen in association with cmv infections (p less than 0.005). | |||||||
| 2827354 | HLA-DR (HLA-DR) | infections | NA | NA | NA | unclassified | |
| from this study we conclude that low percentages of leu2a+ cells correlate with rejection episodes or cmv infections, whereas low percentages together with increased percentages of leu2a+dr+ and leu2a+leu15+ cells are associated with cmv infections, especially in patients treated with high doses of cyclosporine. | |||||||
| 2830687 | MHC (MHC) | transplantation | NA | NA | NA | unclassified | |
| after transplantation, this pattern of mhc expression was markedly modified. | |||||||
Copyright 2024